Nagio Takigawa    Department   Kawasaki Medical School  Kawasaki Medical School, Department of General Internal Medicine 4,    Position   Professor
Language	English
Title	A phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small-cell lung cancer with activating EGFR gene mutations: OLCSG 1001
Conference	ESMO 2014 (European Society for Medical Oncology)
Conference Type	International society and overseas society
Presentation Type	Poster notice
Lecture Type	General
Publisher and common publisher	◎Nogami N, Ichihara E, Kozuki T, Kubo T, Kishino D, Kuyama S, Bessho A, Fujii M, Takigawa N, Chikamori K, Aoe K, Nagata T, Fujimoto N, Hosokawa S, Harita S, Kamei H, Ueoka H, Hotta K, Tanimoto M, Kiura K
Date	2014/09/27
Venue (city and name of the country)	Madrid, Spain